載入...

PCSK9 Inhibitors for the Management of Mitotane-Induced Hypercholesterolemia in Adrenocortical Carcinoma

Background: After surgical resection in adrenocortical carcinoma (ACC), mitotane is often used as adjuvant therapy. However, mitotane can cause adverse effects, such as inducing hypercholesterolemia by stimulating HMG-CoA reductase. In addition, mitotane is a strong CYP3A4 inducer which presents a c...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Endocr Soc
Main Authors: Aurora, John A, Erenler, Feyza, Matta, Stephany, Lechan, Ronald M
格式: Artigo
語言:Inglês
出版: Oxford University Press 2021
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC8089732/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.634
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!